Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-27T09:16:59.756Z Has data issue: false hasContentIssue false
  • English
  • Français

Thalamic neuropathology in the chronic pilocarpine and picrotoxin model of epilepsy

Published online by Cambridge University Press:  18 April 2006

Clement Hamani  and
Luiz Mello
Clement Hamani
Affiliation:
Depto. de Fisiologia da EPM-UNIFESP, São Paulo, SP 04023-900, Brazil. E-mail addresses:chamani@uol.com.br (C. Hamani), lemello@ecb.epm.br (L.E.A.M. Mello).
Luiz Mello
Affiliation:
Depto. de Fisiologia da EPM-UNIFESP, São Paulo, SP 04023-900, Brazil. E-mail addresses:chamani@uol.com.br (C. Hamani), lemello@ecb.epm.br (L.E.A.M. Mello).
Get access Rights & Permissions [Opens in a new window]

Abstract

Adult male Wistar rats were injected with 150/0.5, 75/1.5 and 50/2.0 mg/kg of pilocarpine (Pilo) and picrotoxin (PTX) (Pilo/PTX mg/kg). The vast majority of the animals developed status epilepticus (SE), after which they were observed for a period of 120–131 days for the occurrence of spontaneous recurrent seizures (SRS). After the experiments, animals were deeply anesthetized, perfused with a 10% formaldehyde fixative solution and their brains were processed with cresyl violet, Perls and Von Kossa techniques. Cell counts were performed under a regular microscopic grid in diverse anteroposterior levels of the thalamus. Several thalamic nuclei in the epileptic groups, particularly the central medial, central lateral, paracentral, mediodorsal, laterodorsal and lateroposterior, showed intense cell loss, pathologic calcification and iron tissue deposits. Our results are relevant to support the importance of the thalamus in the pathogenesis of the epilepsies.

Keywords

ThalamusPilocarpineEpilepsyEpilepsy surgeryTemporal lobe epilepsy
Type
Research Article
Information
Thalamus & Related Systems , Volume 2 , Issue 1 , December 2002 , pp. 49 - 53
Copyright
2002 Elsevier Science Ltd

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)